Peter Zandstra is the Tier 1 Canada Research Chair in Stem Cell Bioengineering and Professor in the Institute of Biomaterials and Biomedical Engineering at the University of Toronto. Dr. Zandstra's work integrates engineering and biology. He is the founder of cord blood stem cell company, Insception, and is the Chief Scientific Officer of CCRM. He brings his expertise in cell manufacturing and commercialization to M3.